Overview

ORAL T-8 Oral Testosterone for Male Hormonal Contraception

Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test how the body absorbs a new form of oral testosterone (T). On Day 1 and Day 9 there are overnight stays in the General Clinical Research Center at the University of Washington to monitor blood testosterone levels over a 24-hour period.
Phase:
Phase 1
Details
Lead Sponsor:
University of Washington
Collaborator:
GlaxoSmithKline
Treatments:
Acyline
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate